Pular para o conteúdo principal
Ranking Invest

DBVT - DBV Technologies S.A.

Segmento: HealthcareDBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

Análise Ranking Invest

Valuation estimado
-$ 274.05 Mi
Valor de Mercado
$ 765.39 Mi
Desconto (AV)-379.3%
IVR
-0.36A companhia vale -0,36 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
-0.59O valuation alternativo equivale a -59% do valor de mercado da companhia.
MLL
-0.59O lucro líquido dos controladores em 16 trimestres equivale a -59% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 160.40 Mi

Dívida Líquida

-$ 174.90 Mi

L4T

-$ 175.99 Mi

MM4T

-5161.36%

Indicadores Básicos

ROE

-109.72%

Índices de Previsibilidade

Receita Líquida

G0.74

Lucro

B0.22

Margem

F3.42

Índices de Tendência

Receita Líquida

D-1.62

Lucro

G-8.53

Margem

G-8.57

Índices de Endividamento

DIV/PAT

-1.09

DIV/L4T

0.99

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.